PDGFRB and AIDS: In accordance with the promising results of the Imatinib AIDS-KS trials [33, 34], pharmacological intervention of PDGFR-signaling in mECK36 KS-like tumors, indicate that it is critical for KSHV-induced tumorigenesis.